Fibrosis progression in initially mild chronic hepatitis C

Journal of Viral Hepatitis

Volumn 13, Issue 5, 2006, Pages 297-302

  Boccato, S ^a   Pistis, R ^a   Noventa, F ^a   Guido, M ^a   Benvegnu L ^a   Alberti, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Liver fibrosis; Mild chronic hepatitis C; Natural history

Indexed keywords

ANTIVIRUS AGENT; INTERFERON; RIBAVIRIN;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEPATITIS C; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PARAMETER; PRIORITY JOURNAL; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ALCOHOL DRINKING; BIOPSY; COHORT STUDIES; DISEASE PROGRESSION; FATTY LIVER; FEMALE; HEPACIVIRUS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 33645960696     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00683.x     Document Type: Article

References (25)

1. Wasley A Alter MJ Epidemiology of hepatitis C: geographic differences and temporal trends Semin Liver Dic 2000 20 1 16
2. National Institutes of Health National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis C: 2002-June 10-12, 2002 Hepatology 2002 36 Suppl.1 S3 S20
3. Alberti A Chemello L Benvegnù L Natural history of hepatitis C J Hepatol 1999 31 Suppl.1 17 24
4. Tremolada F Casarin C Alberti A et al. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis J Hepatol 1992 16 273 281
5. Seef LB Buskell-Bales Z Wright EC et al. Long-term mortality after transfusion associated non-A, non-B hepatitis N Engl J Med 1992 327 1906 1911
6. Kenny-Walsh E Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group N Engl J Med 1999 340 1228 1233
7. Tong MJ El-Farra NS Reikes AR Co RJ Clinical outcomes after transfusion associated hepatitis C N Engl J Med 1995 332 1463 1466
8. Alberti A Noventa F Benvegnù L Boccato S Gatta A Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection Ann Intern Med 2002 137 961 964
9. EASL EASL International Consensus Conference on Hepatitis C. Paris, 26-27 February 1999. Consensus Statement J Hepatol 1999 31 Suppl.1 3 8
10. Ghany MG Kleiner DE Alter H et al. Progression of fibrosis in chronic hepatitis C Gastroenterology 2003 124 97 104
11. Hui C-K Belaye T Montegrande K Wright TL A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase J Hepatol 2003 38 511 517
12. Shev S Dhillon AP Lindh M et al. The importance of cofactors in the histological progression of minimal and mild chronic hepatitis C Liver 1997 17 215 223
13. Marcellin P Asselah T Boyer N Fibrosis and disease progression in hepatitis C Hepatology 2002 36 Suppl. 1 S47 S56
14. Poynard T Bedossa P Opolon P Natural history of liver fibrosis progression in patients with chronic hepatitis C Lancet 1997 349 825 832
15. Bedossa P Poynard T for the METAVIR Cooperative Study Group An algorithm for the grading activity in chronic hepatitis C Hepatology 1996 24 289 293
16. Manns MP McHutchison JG Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 2001 358 9286 958 965
17. Fried MW Shiffman ML Reddy KR et al. Combination of peg-interferon alfa-2a plus ribavirin in patients with chronic hepatitis C virus infection N Engl J Med 2002 347 975 982
18. Davis A Albright J Cook S Rosenberg D Projecting future complications of chronic hepatitis C in the United States Liver Transplant 2003 9 4 331 338
19. Deuffic S Buffat L Poynard T Valleron AJ Modelling the hepatitis C virus epidemic in France Hepatology 1999 29 1596 1601
20. Zeuzem S Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well? Ann Inter Med 2004 140 370 381
21. Ryder SD Trent Hepatitis C Study Group Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study Gut 2004 53 451 455
22. Alberti A Boccato S Ferrari A Benvegnù L Pontisso P Noventa F Outcome of initially mild chronic hepatitis C (abstract) Hepatology 2001 34 225A
23. Poynard T Ratziu V Charlotte F Goodman Z McHutchison J Albrecht J Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C J Hepatol 2001 34 730 739
24. Lagging LM Westin J Svensson E et al. Progression of fibrosis in untreated patients with hepatitis C virus infection Liver 2002 22 136 144
25. Castéra L Hézode C Roudot-Thoraval F et al. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies GUT 2003 52 288 292